Idiopathic bronchiectasis

Posted 1 week ago by Wales Gene Park

Brief Summary: The primary objective of this study is to evaluate the effect of brensocatib at 10 mg and 25 mg compared with placebo on the rate of pulmonary exacerbations (PEs) over the 52-week treatment period.

 Idiopathic bronchiectasis /  Swansea


No post found